V. de Pangher Manzini
Research Subjects
Research Interests
V. de Pangher Manzini has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Alessandra Bearz
CRO Aviano, National Cancer Institute, IRCCS, Aviano, Italy
2 shared publications - Adolfo Favaretto
Azienda ULSS 2 Marca Trevigiana, Treviso, Italy
1 shared publication - Antonio Santo
General Hospital, GIVOV, Verona, Italy
1 shared publication - Camillo Porta
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari and University of Bari "A. Moro," Bari, Italy
1 shared publication - Eleonora Berto
Centro di Riferimento Oncologico di Aviano (CRO), Department of Medical Oncology, IRCCS, 33081 Aviano, Italy
1 shared publication F. Morelli
Department of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico, Casa Sollievo della Sofferenza, San Giovanni Rotondo
1 shared publication
Latest Publications
- Open Access
- 3 September 2012
- Published by Springer Nature in BMC Research Notes
- Vol. 5 (1) , 482
Re-challenge with pemetrexed in advanced mesothelioma: a multi-institutional experience
Although first-line therapy for patients affected by advanced mesothelioma is well established, there is a lack of data regarding the impact of second-line treatment.
- 3 September 2012
- Published by Springer Nature in BMC Research Notes
- Vol. 5 (1) , 482
Open AccessRe-challenge with pemetrexed in advanced mesothelioma: a multi-institutional experience
Although first-line therapy for patients affected by advanced mesothelioma is well established, there is a lack of data regarding the impact of second-line treatment.
- Open Access
- 27 July 2009
- Published by Elsevier in Annals of Oncology
- Vol. 21 (2) , 348-353
Malignant peritoneal mesothelioma: a multicenter study on 81 cases
Background: Malignant peritoneal mesothelioma (MPM) is a rare disease characterized by a difficult diagnosis, different types of presentation, variable course and poor prognosis. Materials and methods: Eighty-one patients with MPM observed in 14 Italian oncology institutions from 1982 to 2007 have been examined with the aim of delineating the history of MPM. Results: Presentation symptoms were ascites, abdominal pain, asthenia, weight loss, anorexia, abdominal mass, fever, diarrhea and vomiting in various associations. Computed tomography scan and echotomography signs were ascites, abdominal mass and peritoneal thickening. Peritoneal fluid cytology (61 cases) was positive for mesothelioma in 31 and for malignancy, not mesothelioma, in 13. Laparoscopy was carried out in 40 cases and laparotomy in 36. Thrombocytosis was present in 59 cases. Associated tumors diagnosed during the lifetime were colorectal cancer in two cases and cheek carcinoma, thyroid carcinoma, tongue carcinoma, bladder carcinoma and testicular seminoma. Thirty patients were treated with surgery and 45 with chemotherapy. The median survival time from diagnosis is 13 months. Ascites, fever and vomiting were significative variables at presentation; only vomiting holds significance in a multivariate analysis. Conclusions: MPM is a disease with various types of presentation, frequently associated with thrombocytosis, sometimes with other tumors. Survival and diagnosis time can differ in various types of MPM. Prognosis is poor.
- 27 July 2009
- Published by Elsevier in Annals of Oncology
- Vol. 21 (2) , 348-353
Open AccessMalignant peritoneal mesothelioma: a multicenter study on 81 cases
Background: Malignant peritoneal mesothelioma (MPM) is a rare disease characterized by a difficult diagnosis, different types of presentation, variable course and poor prognosis. Materials and methods: Eighty-one patients with MPM observed in 14 Italian oncology institutions from 1982 to 2007 have been examined with the aim of delineating the history of MPM. Results: Presentation symptoms were ascites, abdominal pain, asthenia, weight loss, anorexia, abdominal mass, fever, diarrhea and vomiting in various associations. Computed tomography scan and echotomography signs were ascites, abdominal mass and peritoneal thickening. Peritoneal fluid cytology (61 cases) was positive for mesothelioma in 31 and for malignancy, not mesothelioma, in 13. Laparoscopy was carried out in 40 cases and laparotomy in 36. Thrombocytosis was present in 59 cases. Associated tumors diagnosed during the lifetime were colorectal cancer in two cases and cheek carcinoma, thyroid carcinoma, tongue carcinoma, bladder carcinoma and testicular seminoma. Thirty patients were treated with surgery and 45 with chemotherapy. The median survival time from diagnosis is 13 months. Ascites, fever and vomiting were significative variables at presentation; only vomiting holds significance in a multivariate analysis. Conclusions: MPM is a disease with various types of presentation, frequently associated with thrombocytosis, sometimes with other tumors. Survival and diagnosis time can differ in various types of MPM. Prognosis is poor.